Healthcare, Technology Dec 31, 2021 11:18 AM (GMT+8) · EqualOcean
Boyuan capital announced that it had completed the raising of RMB phase II fund and was oversubscribed, with a total subscription scale of more than 3 billion yuan. It is reported that since its surrender, Boyuan RMB phase II fund has invested in more than a dozen enterprises, such as Boya serine, Diluo, feitland, qicarbon technology, tengfu medical treatment and Zhixiang biology. Boyuan capital is an investment institution focusing on investing and incubating Chinese medical and health start-ups.
Related companies: